Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 155

Results For "report"

1994 News Found

Soligenix receives US patent allowance for its thermostabilized vaccine platform
Biotech | May 23, 2022

Soligenix receives US patent allowance for its thermostabilized vaccine platform

Includes thermostabilized Ebola vaccines


Novavax files for expanded conditional marketing authorisation for Nuvaxovid as a booster in Europe
News | May 21, 2022

Novavax files for expanded conditional marketing authorisation for Nuvaxovid as a booster in Europe

The European Commission granted CMA in December 2021 for use of Nuvaxovid in individuals aged 18 and over, and Novavax filed for expanded CMA for use in adolescents aged 12 through 17 in March 2022


Havas Health & You appoints Dan Rubin as President of Havas Health +
People | May 20, 2022

Havas Health & You appoints Dan Rubin as President of Havas Health +

Key senior hire will partner with Allison Ceraso, President and CCO, bolstering agency leadership amongst continued network momentum


Pharma companies with ESG more valuable say investors
Sustainability | May 20, 2022

Pharma companies with ESG more valuable say investors

When asked how to balance ESG with broader business goals, the panel was unanimous in its assessment that ESG is ‘good for business’


Bristol Myers Squibb highlights progress in treatment for cancer and blood disorders
Biotech | May 20, 2022

Bristol Myers Squibb highlights progress in treatment for cancer and blood disorders

First disclosure from PILOT study of Breyanzi in second-line large B-cell lymphoma underscores important role of cell therapy earlier in treatment paradigm


USFDA urges drug manufacturers to develop risk management plans to promote a stronger, resilient drug supply chain
Supply Chain | May 20, 2022

USFDA urges drug manufacturers to develop risk management plans to promote a stronger, resilient drug supply chain

Risk management plans can serve as a safeguard, helping manufacturers prepare for and respond to hazards that could lead to drug supply disruptions and shortages


Motilal Oswal Private Equity (MOPE) invests  in Pathkind Diagnostics
Clinical Trials | May 20, 2022

Motilal Oswal Private Equity (MOPE) invests in Pathkind Diagnostics

A primary investment of Rs 194.4 crore has been made


CK Birla doctors perform rare laparoscopic surgery on seven-year-old for chronic pancreatitis
Hospitals | May 18, 2022

CK Birla doctors perform rare laparoscopic surgery on seven-year-old for chronic pancreatitis

Surgical treatment of chronic pancreatitis is challenging in children and especially laparoscopic surgery has been rarely reported, worldwide


RadNet’s AI subsidiaries obtain USFDA clearance for mammography and prostrate AI tools
Drug Approval | May 17, 2022

RadNet’s AI subsidiaries obtain USFDA clearance for mammography and prostrate AI tools

Quantib Prostate is an AI-based software solution that advances the MRI prostate reporting workflow and is accessible directly from the radiologist's reading station


Boehringer Ingelheim’s treatment slowed lung function decline in people living with idiopathic pulmonary fibrosis
Biotech | May 16, 2022

Boehringer Ingelheim’s treatment slowed lung function decline in people living with idiopathic pulmonary fibrosis

Potential new treatment for progressive pulmonary fibrosis (PPF) builds on Boehringer Ingelheim’s leadership in lung fibrosis and will be further investigated in a phase III clinical trial program